FDA Approves Nasal Spray For Suicidal People
FDA APPROVES A DRUG TO TREAT PEOPLE WITH SERIOUS SUICIDAL THOUGHTS
(CNN) – The Food and Drug Administration has approved a new treatment for suicide people.
On Monday the nasal spray, Spravato was approved as an antidepressant medication.
It’s the first and only approved medicine that has been shown to reduce depressive symptoms in people with serious suicidal thoughts within 24 hours of taking it.
Last year Spravato was green lighted for patients with treatment-resistant depression.
According to the drug’s maker, researchers believe Spravato can also rapidly reduce symptoms of depression.
The company says it does not know if Spravato is effective in preventing suicide, but it is not a substitute for hospitalization and clinical treatments.